Worldwide, almost 1 in 10 people become ill each year from foodborne disease. This equates to 33 million healthy life years lost. Out of 550 million diarrheal diseases resulting from foodborne illnesses, 220 million are in children under 5 years old. Tragically, fatalities among that patient population number 96,000 per year.1 Conventional detection methods for enteric pathogens are complex and time-consuming. Results can take several days, creating laboratory burden and greatly complicating patient management.
The BD MAX™ Enteric Solutions portfolio addresses complex patient needs through unique, versatile assay design. A targeted panel approach allows for test selection based on clinical presentation. Materials and labor for the stool bench are greatly reduced, and results are available in hours instead of days.2 Increased diagnostic accuracy and timely results, compared to traditional methods, enable prompt clinical decisions.3 Learn More>>
Detects over 90% of bacterial organisms causing infectious gastroenteritis.4 Learn More>>
Extends testing coverage to lower-prevalence bacterial pathogens.5 Learn More>>
Detects 3 commonly isolated and highly pathogenic parasites that cause gastroenteritis.6 Learn More>>
Broad coverage of key viral pathogens – Norovirus, Rotavirus, Adenovirus (40/41), Sapovirus and Human Astrovirus.
BD MAX Enteric Viral Panel is under FDA review. Product not for sale in the U.S.